Gene and Cell Therapies for Beta-Globinopathies / edited by Punam Malik, John Tisdale.

Format:

Book

Contributor:

Malik, Punam, editor.

Tisdale, John, active 1557-1563, editor.

SpringerLink (Online service)

Series:

Biomedical and Life Sciences (Springer-11642)

American Society of Gene & Cell Therapy, 2626-7713 ; 1013.

American Society of Gene & Cell Therapy, 2626-7713 ; 1013

Language:

English

Subjects (All):

Gene therapy.

Cytology.

Gene Therapy.

Cell Biology.

Local Subjects:

Gene Therapy.

Cell Biology.

Physical Description:

1 online resource (XII, 248 pages) : 16 illustrations, 12 illustrations in color.

Edition:

First edition 2017.

Contained In:

Springer eBooks

Place of Publication:

New York, NY : Springer New York : Imprint: Springer, 2017.

System Details:

text file PDF

Summary:

This book provides a comprehensive review of gene and cell therapy approaches for hemoglobinopathies. It covers the progress and current state of the field in hematopoietic stem cell transplantation for hemoglobinopathies and genetic correction of autologous hematopoietic stem cells. Chapters focus on such topics as the current standards of care and long term outcomes of b-thalassemias and sickle cell disease, the ability to generate autologous embryonic stem cell-like cells from primary somatic cells, and genetic strategies to reactivate fetal hemoglobin production. In addition to offering a thorough review of the field in its present state, this book also sheds light on the major changes expected in coming years. Gene and Cell Therapies for Beta-Globinopathies is part of the American Society of Gene and Cell Therapy sub-series of the highly successful Advances in Experimental Medicine and Biology series. It is essential reading for graduate students, clinicians, and researchers interested in gene and cell therapy.

Other Format:

Printed edition:

ISBN:

978-1-4939-7299-9

9781493972999

Access Restriction:

Restricted for use by site license.